We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a cost consequence analysis to evaluate your digital health product.
Guidance on the ventilation of indoor spaces to reduce the spread of respiratory infections, including coronavirus (COVID-19).
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Guidance on Animal Test Certificates (ATCs) required to carry out the field trial of a veterinary medicine in animals (clinical trial) in the UK.
How to use a cost utility analysis to evaluate your digital health product.
Proposes the introduction of fixed recoverable costs and a new streamlined process in clinical negligence claims up to a value of £25,000 in England and Wales.
How to use a randomised controlled trial to evaluate your digital health product.
A planning tool to examine factors that influence stillbirth and infant death at the population level, rather than in individual clinical care.
Information for patients, public and health care professionals.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
The following guidance has been jointly developed by the Heath Research Authority (HRA) and MHRA, in consultation with the Information Commissioners Office (ICO), on behalf of the UK.
How to use a factorial randomised controlled trial to evaluate your digital health product.
How to use a crossover randomised controlled trial to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.